Trials / Withdrawn
WithdrawnNCT00954668
ImmeDiate Versus EArLy Invasive Approach in Non-ST-Elevation Myocardial Infarction (IDEAL NSTEMI)
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Leipzig · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Of estimated 140,000 cases of acute myocardial infarction admitted to hospitals in Germany per year, approximately 50% present with Non-ST-elevation myocardial infarction (NSTEMI). The currently available evidence led to current guideline recommendations that a systematic approach of immediate angiography in NSTEMI patients stabilized with contemporary antiplatelet treatment is not mandatory. However, this immediate invasive approach is appealing because it allows treating the underlying cause (the plaque rupture) as early as possible with subsequent reduction of death and recurrent myocardial infarction. In the IDEAL NSTEMI trial we test an immediate invasive approach (\<2 h) with an approach 12-72 h according top guidelines with respect to 6 months death and mortality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | immediate angiography and revascularization | immediate angiography \< 2 hours after randomization |
| PROCEDURE | early invasive angiography | early invasive angiography 12-72 h after randomization |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-01-01
- Completion
- 2009-01-01
- First posted
- 2009-08-07
- Last updated
- 2018-07-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00954668. Inclusion in this directory is not an endorsement.